ALK Inhibitor Alectinib Hydrochloride CAS Number 1256589-74-8

Unit Price: USD 1.0000 / Kilogram
Payment Type: T/T
Incoterm: CIF
Min. Order: 1 Kilogram
Delivery Time: 15 Days

Basic Info

Model No.:  1256589-74-8

Additional Info

Packaging: AS REQUIRED

Productivity: KGS


Transportation: Air

Place of Origin: CHINA


Product Description

The new anaplastic lymphoma kinase (ALK) inhibitor Alectinib hydrochloride CAS 1256589-74-8, It has been obtained the FDA breakthrough therapeutic drug qualification, accelerated approval as a new oral anti-lung cancer drug for the treatment of ALK gene mutation Advanced metastatic non-small cell lung cancer. It has high efficiency in inhibiting tumor activity and high safety. Its comprehensive preclinical studies have shown that oral Alectinib is safe, its molecular mechanism of anti-tumor effect is clear, and it is highly specific and specific, and its inhibitory effect on EGFR/ErbB1 and ErbB2 tyrosine kinase is obvious. Solid malignant tumors such as cell lung cancer have significant curative effects, and are also suitable for patients who have deteriorated or are not tolerated after treatment with another therapeutic drug, crizotinib. It was approved by the US FDA in December 2015.
     In the literature report, there are two main methods for the synthesis of Alectinib hydrochloride CAS 1256589-74-8. The first one is based on 7-methoxy-3,4-dihydronaphthalene-2(1H)-one. Through 8 Step reaction to obtain. This method constructs an anthracene ring through phenylhydrazine to finally complete the synthesis of Alectinib hydrochloride. The route design of this method is too long and the total product yield is too low.
The second method is prepared by 5-step reaction using 3-iodo-4-ethyl-tert-butylbenzene as a starting material. This method is carried out by reduction of m-cyanonitrobenzene to an amino group to form an anthracene ring, which is finally completed Synthesis of Alectinib hydrochloride.
The core of these two methods are synthetic anthracene rings. However, due to the multiple functional groups of the substrate, the reaction process is quite complicated, the purification is difficult, and the total yield of the reaction is greatly limited by the step of synthesizing the anthracene ring. Aiming at the defects existing in the existing technology, it is of practical significance to develop a new and simple process and find a process technology that can adapt to industrial production,It has practical significance for large-scale application of Alectinib hydrochloride CAS 1256589-74-8.
Thera. Category: Anti Cancer

Cas No.: 1256589-74-8

Synonyms: AF-802 Hydrochloride;Alectinib Hydrochloride;CH5424802 Hydrochloride;CH-5424802 Hydrochloride;RG-7853 Hydrochloride


Molecular Formula:C30H37ClN4O2

Molecular Weight:521.09338

Purity: ≥98%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Active Pharmaceutical Ingredients> Cas 90098-04-7,Rebamipide Named In Mucosta With GMP Standard
Active Pharmaceutical Ingredients> Functional Dyspepsia Treatment Acotiamide Hydrochloride Trihydrate CAS 773092-05-0
Active Pharmaceutical Ingredients> Acotiamide Hydrochloride For Gastric Motility Improvement CAS 185104-11-4
Contract Manufacturing> ASCORBYL GLUCOSIDE Used for Comesitc Additive CAS 129499-78-1
Pharmaceutical Intermediates> Anti-Ulcerative> 2-Aminothiazole-4-ethylformate For Making Acotiamide Cas 5398-36-7
Pharmaceutical Intermediates> Anti-Ulcerative> Acotiamide INT CAS NUMBER 185105-98-0
Pharmaceutical Intermediates> Anti-Cardiovascular> Azilsartan Used for Hypertension Treatment CAS 147403-03-0
Pharmaceutical Intermediates> Anti-Diabetes> Sitagliptin Phosphate Monohydrate Treated for Type 2 diabetes CAS Number 654671-77-9
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 132210-24-3, 2-Amino-3-(1,2-dihydro-2-oxo-quinoline-4-yl)Propanoic acid Hydrochloride For Rebamipide
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 1068-90-2 White Crystalline Powder Diethyl Acetamidomalonate For Rebamipide(DAAM)
Active Pharmaceutical Ingredients> 6027-23-2, Hordenine HCL Powder
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 4876-10-2,4-Bromomethyl-2(1H)-quinolinone (BMQ) For Rebamipide/ Mucosta
Pharmaceutical Intermediates> Anti-Respiratory> CAS 2338-18-3, 2-Aminoindan hydrochloride For Making Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> CAS 312753-53-0/ 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride Used for Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> 312753-53-0, Indacaterol Intermediate
Pharmaceutical Intermediates> Anti-Respiratory> 100331-89-3, Indacaterol Intermediate

© 2019 CHINA WAY. All Rights Reserved.  Taizhou Volsen Chemical Co., Ltd.,  Inc.   All rights reserved. site map.  sitemap.html